Specialty pharmaceutical company focused on the development of pediatric friendly therapeutics for the treatment of orphan renal diseases and neurology.
Total raised: $29.07M
Investors 2
| Date | Name | Website |
| - | Femmes Bus... | femmesbusi... |
| - | Crealia | crealia.or... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.06.2021 | - | $11.89M | - |
| 20.03.2017 | - | $17.18M | - |
Mentions in press and media 18
| Date | Title | Description | Source |
| 04.01.2022 | Advicenne announces commercialization agreement with FrostPh... | Advicenne announces commercialization agreement with FrostPharma AB for Sibnayal™ in the Nordic regi... | globenewsw... |
| 20.12.2021 | Advicenne Announces Positive Opinion From the French Transpa... | Regulatory News: Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to devel... | marketscre... |
| 20.12.2021 | Advicenne announces positive opinion from the French Transpa... | Advicenne announces positive opinion from the French Transparency Commission (HAS) for its drug Sibn... | globenewsw... |
| 20.12.2021 | Advicenne announces positive opinion from the French Transpa... | Advicenne announces positive opinion from the French Transparency Commission (HAS) for its drug Sibn... | marketscre... |
| 07.12.2021 | Advicenne announces significant progress in marketing its le... | Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe First rou... | globenewsw... |
| 29.09.2021 | Advicenne : September 29, 2021 - Advicenne Reports 2021 Half... | Advicenne Reports 2021 Half Year Financial Results Paris, France, 29 September 2021 - 7:00AM (CEST)... | marketscre... |
| 02.07.2021 | Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV710... | Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of dRTA ... | marketscre... |
| 02.07.2021 | Advicenne : July 2, 2021 - Advicenne Receives MHRA Approval ... | Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of dRTA ... | marketscre... |
| 22.06.2021 | Advicenne : June 22, 2021 - Advicenne launches a reserved ca... | The following pages contain information regarding the share capital increase of Advicenne. For regul... | marketscre... |
| 22.06.2021 | Advicenne : June 21, 2021 - Advicenne launches a reserved ca... | The following pages contain information regarding the share capital increase of Advicenne. For regul... | marketscre... |
Show more